This case report aims to present a rare but significant type of complication that every ophthalmologist performing Selective Laser Trabeculoplasty (SLT) should be aware of due to the anatomical changes it generates, as well as refractive changes and to understand the treatment and duration of resolution or semi-resolution of this condition.
Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet. 2004;363(9422):1711-1720.
Kass MA, Heuer DK, Higginbotham BJ, et al. The ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002; 120(6):701-713.
The AGIS Investigators the Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. AM J Ophthalmol. 2000;130(4):429-440.
Medeiros FA, Alencar LM, Zangwill LM, et al. The relationship between intraocular pressure and progressive retinal nerve fiber layer loss in glaucoma. Ophthalmology. 2009;116:1125-1133.
Nouri-Mahdavi, Caprioli J. Measuring rates of functional change in glaucoma. Br. J Ophtalmol. 2015;99:893-898.
Royal College of Ophthalmologists. Focus in Ophthalmology – Glaucoma Management. URL: www.mrcophth.com/focus1/Glaucoma%20Management.htm
Kirwan JF, Nightingale JA, Bunce C, Wormald R. Beta blockers for glaucoma an excess risk of airways obstruction: population based cohort study. BMJ 2002; 325:1396-7.
Balkrishnan R, Bond JB, Byerly WG, Camacho FT, Anderson RT. Medication-related predictors of health-related quality of life in glaucomapatients enrolled in a Medicare health maintenance organization. AM J Geriatr Pharmacother 2003;1:75-81.
Broadway DC, Grierson I, O'Brien C, Hitchings RA. Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery. Arch Ophthalmol 1994; 112: 1446-54.
Schwartz GF, Quigley HA. Adherence and persistence with glaucoma therapy. Surv Ophthalmol. 2008;53(Suppl. 1):S57-68.
Garg A, Gazzard G. Selective laser trabeculoplasty: past, present, and future. Eye 2018;32: 863-76.
Waisbourd M, Kats J. Selective laser trabeculoplasty as a first-line therapy: a review. Can J Ophthalmol 2014; 49:519-522.
Kim Dy, Singh A. Severe iritis and choroidal effusion following selective laser trabeculoplasty. Ophthalmic Surg Lasers Imaging. 2008: 39:409-11.
White Aj, Mukherjee A, Hanspal I, Sarkies NJ, Maritn KR, Shah P. Acute transient corneal endothelial changes following selective laser trabeculoplasty. Clin Experiment Ophthalmol. 2013; 41: 435-41.
Shihadeh WA, Ritch R, Liebmann JM. Hyphema occurring during selective laser trabeculoplasty. Ophthalmic Surg Lasers Imaging. 2006; 37: 432-3.
Liyanage SE, Kumaran N, De Alwis D. Macular burns resulting from the accidental use of selective laser trabeculoplasty mode during a laser capsulotomy. Br. J Ophthalmol. 2014;98:141-2.
Harasymowycz PJ, Papamatheakis DG, Latina M, De Leon M, LEsk MR, Damji KF. Selective laser trabeculoplasty (SLT) complicated by intraocular pressure elevation in eyes with heavily pigmented trabecular meshwork. Am J Ophthalmol. 2005;139:1110-3.
Paiva ACM, da Fonseca AS. Could adverse effects and complications of selective laser trabeculoplasty be decreased by low-power laser therapy? Int Ophtalmol. 2019;39(1):243-257.
Knickelbein JE, Singh A, Flowers BE, et al. Acute corneal edema with subsequent thinning and hyperopic shift following selective laser trabeculoplasty. J Cataract Refract Surg. 2014;40(10):1731-1735.
Song J, Yu D, Song A, Palmares TS, Song H, Song M. Corneal thinning and opacity following selective laser trabeculoplasty: a case report. J Adv Med Med Res. 2013;4 (1): 279-287.
